Previous evidence shows that G. lucidum can improve intestinal flora dysbiosis and reduce AOM/DSS-induced colitis and tumorigenesis by inhibiting TLR4/MyD88/NF-κB pathway (Guo et al., 2021). The gene discussed is TLR4; the disease is infectious otitis media.